Schedule 13G ownership disclosure

Tracon Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 89237H100

Event date: 2015-02-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,817,670
Percent of class
15.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-008890
Form type
SC 13G
Filer
JAFCO Super V3 Investment Limited Partnership
CIK
CIK 1590442
Filed
Feb 13, 2015
Reporting period
Feb 04, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub